Skip to Content

Sopharma AD-Sofia SFA

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SFA is trading within a range we consider fairly valued.
Price
BGN 6.32
Fair Value
BGN 8.50
Uncertainty
High
1-Star Price
BGN 8.89
5-Star Price
BGN 5.82
Economic Moat
Lwq
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SFA is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
9.66
Price/Sales
0.46
Dividend Yield (Trailing)
24.19%
Dividend Yield (Forward)
24.19%
Total Yield
24.19%

Company Profile

Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are organized based on the production of finished products which include Tablet dosage forms, Ampoule dosage forms, Medical products, Other forms, and Other revenue. Geographically company operates in Bulgaria and internationally.
Sector
Healthcare
Industry
Medical Distribution
Stock Style Box
Small Core
Total Number of Employees
4,721

Comparables

Valuation

Metric
SFA
600557
603567
Price/Earnings (Normalized)
9.6626.94
Price/Book Value
1.362.381.30
Price/Sales
0.462.502.26
Price/Cash Flow
19.5016.75
Price/Earnings
SFA
600557
603567

Financial Strength

Metric
SFA
600557
603567
Quick Ratio
0.742.191.89
Current Ratio
1.292.522.43
Interest Coverage
10.575.77
Quick Ratio
SFA
600557
603567

Profitability

Metric
SFA
600557
603567
Return on Assets (Normalized)
7.10%7.32%−1.52%
Return on Equity (Normalized)
13.81%10.08%−2.46%
Return on Invested Capital (Normalized)
9.78%9.25%−0.79%
Return on Assets
SFA
600557
603567
See how this stock stacks up to its competitors with Morningstar Investor

Medical Distribution Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MCK
McKesson CorpQfxcvqjBdjtyv$70.5 Bil
COR
Cencora IncGzgxngfzJfsvgv$48.4 Bil
CAH
Cardinal Health IncMsvhdgfyRclwf$27.2 Bil
AMFPF
Amplifon SpA Az nom Post FrazionamentoBscppd$8.2 Bil
SHTDY
Sinopharm Group Co Ltd ADRMbdp$8.0 Bil
SHTDF
Sinopharm Group Co LtdPgkkh$8.0 Bil
SHPMY
Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class HYqgt$7.9 Bil
SHPMF
Shanghai Pharmaceuticals Holding Co Ltd Class HJjp$6.6 Bil
MAHLY
Medipal Holdings Corp ADRSyvl$3.2 Bil
MEPDF
Medipal Holdings CorpBxxd$3.2 Bil

Sponsor Center